A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD)

NCT01875718 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Premenstrual Dysphoric Disorder

Interventions

DRUG: UC1010
DRUG: Placebo

Sponsor

Umecrine Mood AB